Actuate Therapeutics IncACTUNASDAQ
Loading
Year-over-year SG&A expense growth
Latest
98.57%
↑ 252% vs avg
Percentile
P100
Near historical high
Streak
1 yr
Consecutive growthAccelerating
Average
28.02%
Historical baseline
| Period | Value |
|---|---|
| 2024 | 98.57% |
| 2023 | -14.51% |
| 2022 | 0.00% |